APA (7th ed.) Citation

Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., . . . Sakin, A. (2023). Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-10609-8

Chicago Style (17th ed.) Citation

Karacin, Cengiz, et al. "Efficacy of Subsequent Treatments in Patients with Hormone-positive Advanced Breast Cancer Who Had Disease Progression Under CDK 4/6 Inhibitor Therapy." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-10609-8.

MLA (9th ed.) Citation

Karacin, Cengiz, et al. "Efficacy of Subsequent Treatments in Patients with Hormone-positive Advanced Breast Cancer Who Had Disease Progression Under CDK 4/6 Inhibitor Therapy." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-10609-8.